Show simple item record

dc.contributor.author Vernon, J.M. en_US
dc.contributor.author Grabowski, Henry en_US
dc.date.accessioned 2010-03-09T15:23:58Z
dc.date.available 2010-03-09T15:23:58Z
dc.date.issued 1986 en_US
dc.identifier.uri http://hdl.handle.net/10161/1848
dc.description.abstract In this paper we analyze its likely impacts on competition in the pharmaceutical industry, the incentives for innovation, and general consumer welfare. en_US
dc.format.extent 553678 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US
dc.publisher American Economic Review en_US
dc.subject 1984 Drug Act en_US
dc.subject Imitation barriers en_US
dc.subject Impact of ANDAs en_US
dc.subject Longer patents en_US
dc.title Longer Patents for Lower Imitation Barriers: The 1984 Drug Act en_US
dc.type Journal Article en_US
dc.department Economics

Files in this item

This item appears in the following Collection(s)

Show simple item record